Evaluation the efficacy of polyamine-deprived dietary regimen Lung cancer

Evaluation the efficacy of polyamine-deprived dietary regimen on Angiogenic growth factors and Tumor markers in patients with Lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016020626390N1

Enrollment

Registered

2016-06-18

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer. Malignant neoplasm of bronchus and lung

Interventions

In control group by the Adjusted Ideal Body weight will be under supervision of Dietition,

Intervention 1: Patients will experience poly amine restricted diet under supervision of of dietition for 6 month intervention group. Intervention 2: In control group by the Adjusted Ideal Body weight

Treatment - Other

Patients will experience poly amine restricted diet under supervision of of dietition for 6 month intervention group

Eligibility

Sex/Gender

All

Age

16 Years to 88 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: age between 30 to 70; healthy function of liver and kidney; lung cancer diagnosis Exclusion Criteria: Chemotherapy; Food supplement or other dietary regimen; diabetes patients

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hepatic Growth Factor. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Eidermal Growth Factor Receptor. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Matrix MetalloProteinase 2. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;TIMP Metallopeptidase Inhibitor 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Plasminogen Activator Inhibitor 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Urokinase (uPA)-mediated plasminogen activation. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Vascular cell adhesion protein 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Intercellular Adhesion Molecule 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Squamous Cell Carcinoma. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Carcinoembryonic antigen. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Cyfra-21. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Interleukin -10. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Interleukin 2. Timepoint: befor and after. Method of measurement: Labaratory Kits,.	—

Measure

Time frame

Hepatic Growth Factor. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Eidermal Growth Factor Receptor. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Matrix MetalloProteinase 2. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;TIMP Metallopeptidase Inhibitor 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Plasminogen Activator Inhibitor 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Urokinase (uPA)-mediated plasminogen activation. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Vascular cell adhesion protein 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Intercellular Adhesion Molecule 1. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Squamous Cell Carcinoma. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Carcinoembryonic antigen. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Cyfra-21. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Interleukin -10. Timepoint: befor and after. Method of measurement: Labaratory Kits,.;Interleukin 2. Timepoint: befor and after. Method of measurement: Labaratory Kits,.

—

Secondary

Measure	Time frame
Weight. Timepoint: befor and after. Method of measurement: kg.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Ahmadzadeh

Ahwaz Jundishapoor University of Medical Science

m_pedram@gmail.com+98 61 3374 3285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026